RedHill Biopharma (RDHL) announced its plan to submit a UK Marketing Authorisation Application for Talicia for treatment of helicobacter pylori ...
Hosted on MSN14d
Are European biopharma manufacturers ‘nearshoring’?Beyond serving its own manufacturing needs, Europe may also seek to increase biopharma exports to the UK. Though home to a number of innovative biotechs, Quirmbach says, “the UK has not been a ...
The U.K. government is proposing to raise the rebate rate under a national drug cost program, drawing complaints from the ...
Explore Xeris Biopharma's revenue growth, promising pipeline, & thriving products. Learn about their strong outlook & ...
RedHill plans to submit UK MAA1 for Talicia for H. pylori infection, using MHRA's2 new fast-track approval process, referencing FDA approval, with potential UK approval ...
RedHill Biopharma (RDHL) has entered into an exclusive ... Recent positive advice from the UK’s MHRA provided a clear pathway for a UK Marketing Authorization Application for RHB-102 for ...
On Monday, H.C. Wainwright analysts revised their stance on Sutro Biopharma (NASDAQ: NASDAQ:STRO), downgrading the stock from "Buy" to "Neutral." Alongside this change, they significantly lowered the ...
GlobalData on MSN20d
Supply chain uncertainties present opportunities for biopharma couriers in 2025thereby complicating international transport for biopharma companies. Speaking with Pharmaceutical Technology, Walraven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback